An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)

• Status: Completed
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This observational study will assess the execution, efficacy and safety of treatment with MabThera in patients with rheumatoid arthritis. Data from patients receiving MabThera according to local treatment guidelines will be collected for 29 months. Target sample size is 100-200 patients.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hoffmann-La Roche
• Treatments: Rituximab

Criteria

Inclusion Criteria:

• adult patients, >/= 18 years of age

• rheumatoid arthritis

• treatment with rituximab

Exclusion Criteria:

• unable/unwilling to give informed consent to data collection